Discover the challenges of acute myeloid leukaemia linked to inflammatory cell death and the quest for effective therapies.
Appointment aligns Board leadership with Company’s transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ...
New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback